The second Phase I/II trial was a randomised, single-blind, placebo-controlled, escalating double-dose safety study conducted at the Sourasky Medical Center in Tel Aviv, Israel, in which a total
Takeda has executed agreements with Mylan Pharmaceuticals (Mylan), Watson Pharmaceuticals (Watson), Ranbaxy Pharmaceuticals (Ranbaxy), Alphapharm (Alphapharm), Torrent Pharmaceuticals (Torrent) and Sandoz and their respective affiliates, to settle patent
ProBioGen is expected to contribute producer cell line development and process engineering for one of Virdante’s proprietary therapeutic proteins. Virdante Pharmaceuticals claimed that the protein products are unique
Suven said that the patents are valid until 2024 and 2025 respectively. The granted claims of the patents include the class of selective 5-HT compounds discovered by the
The new corporate headquarters, which is slated for completion in the spring of 2012, will be two six-story buildings totaling 425,000sqft and will cost approximately $150m. Astellas Pharma
Merck KgaA has posted a net income of EUR191.4m for the first quarter 2010, or EUR0.88 per diluted share, compared to EUR56.7, or EUR0.26 per diluted share, for
Abbott said that Kaletra once-daily dosing is already indicated for adult patients new to antiretroviral treatment. This gives treatment-experienced patients who have HIV that responds to Kaletra another
DSM posted a net income of EUR130m for the first quarter 2010, or EUR0.78 per diluted share, compared to EUR13m, or EUR0.06 per diluted share, for the prior
Built on the imprint of the highly-successful ACL TOP models, the ACL TOP 700 and ACL TOP 700 CTS offer advanced technology and deliver ‘Testing-Process Automation’ with maximum
Kiadis Pharma said that ATIR continues to show positive clinical results in patients who received a mismatched bone marrow transplantation from a family member donor. ATIR is a
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.